Literature DB >> 22615714

Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.

Jun Shen1, Feng Jiang.   

Abstract

INTRODUCTION: Lung cancer is the leading cause of cancer death worldwide, due to its late diagnosis and poor outcome. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the posttranscriptional levels by either degrading or blocking translation of messenger RNA targets. Accumulating evidence indicates that miRNAs play a pivotal role in the development and progression of human malignancies, including lung cancer. AREAS COVERED: In this review, the authors focus on 1) application of miRNA-based biomarkers to help classify lung cancer, 2) application of the miRNA biomarkers for the early detection of lung cancer, and 3) use of miRNAs as biomarkers to predict outcomes of lung cancer. EXPERT OPINION: MiRNAs provide promising biomarkers for the diagnosis and prognosis of lung cancer. The developed miRNA biomarkers should be comprehensively and prospectively validated in clinical trials before being used in laboratory settings.

Entities:  

Year:  2012        PMID: 22615714      PMCID: PMC3355762          DOI: 10.1517/17530059.2012.672970

Source DB:  PubMed          Journal:  Expert Opin Med Diagn        ISSN: 1753-0059


  72 in total

1.  miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.

Authors:  Sanja Dacic; Lindsey Kelly; Yongli Shuai; Marina N Nikiforova
Journal:  Mod Pathol       Date:  2010-09-03       Impact factor: 7.842

Review 2.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

Authors:  William C S Cho
Journal:  Int J Biochem Cell Biol       Date:  2009-12-22       Impact factor: 5.085

Review 3.  Screening and early detection of lung cancer.

Authors:  Susan C Van't Westeinde; Rob J van Klaveren
Journal:  Cancer J       Date:  2011 Jan-Feb       Impact factor: 3.360

4.  Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.

Authors:  Tom Donnem; Kenneth Lonvik; Katrine Eklo; Thomas Berg; Sveinung W Sorbye; Khalid Al-Shibli; Samer Al-Saad; Sigve Andersen; Helge Stenvold; Roy M Bremnes; Lill-Tove Busund
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

5.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

Authors:  Zhibin Hu; Xi Chen; Yang Zhao; Tian Tian; Guangfu Jin; Yongqian Shu; Yijiang Chen; Lin Xu; Ke Zen; Chenyu Zhang; Hongbing Shen
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.

Authors:  Niels H H Heegaard; Aaron J Schetter; Judith A Welsh; Mitsuhiro Yoneda; Elise D Bowman; Curtis C Harris
Journal:  Int J Cancer       Date:  2011-08-26       Impact factor: 7.396

7.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Authors:  Mattia Boeri; Carla Verri; Davide Conte; Luca Roz; Piergiorgio Modena; Federica Facchinetti; Elisa Calabrò; Carlo M Croce; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

8.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

9.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 10.  MicroRNAs: key regulators of stem cells.

Authors:  Vamsi K Gangaraju; Haifan Lin
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

View more
  21 in total

1.  Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.

Authors:  Jie Ma; Kaiissar Mannoor; Lu Gao; Afang Tan; Maria A Guarnera; Min Zhan; Amol Shetty; Sanford A Stass; Lingxiao Xing; Feng Jiang
Journal:  Mol Oncol       Date:  2014-04-15       Impact factor: 6.603

2.  A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.

Authors:  Yanli Lin; Qixin Leng; Zhengran Jiang; Maria A Guarnera; Yun Zhou; Xueqi Chen; Heping Wang; Wenxian Zhou; Ling Cai; HongBin Fang; Jie Li; Hairong Jin; Linghui Wang; Shaoqiong Yi; Wei Lu; David Evers; Carol B Fowle; Yun Su; Feng Jiang
Journal:  Int J Cancer       Date:  2017-06-21       Impact factor: 7.396

3.  Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer.

Authors:  Ning Li; Jie Ma; Maria A Guarnera; HongBin Fang; Ling Cai; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

4.  Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.

Authors:  Yong Peng; Yuntao Dai; Charles Hitchcock; Xiaojuan Yang; Edmund S Kassis; Lunxu Liu; Zhenghua Luo; Hui-Lung Sun; Ri Cui; Huijun Wei; Taewan Kim; Tae Jin Lee; Young-Jun Jeon; Gerard J Nuovo; Stefano Volinia; Qianchuan He; Jianhua Yu; Patrick Nana-Sinkam; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 5.  MicroRNAs as potential biomarkers in human solid tumors.

Authors:  Jun Shen; Sanford A Stass; Feng Jiang
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

6.  Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.

Authors:  Jie Ma; Yanli Lin; Min Zhan; Dean L Mann; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2015-07-06       Impact factor: 5.662

7.  The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.

Authors:  K Mavridis; F Gueugnon; A Petit-Courty; Y Courty; A Barascu; S Guyetant; A Scorilas
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.

Authors:  Yu Fujita; Shigehiro Yagishita; Keitaro Hagiwara; Yusuke Yoshioka; Nobuyoshi Kosaka; Fumitaka Takeshita; Tomohiro Fujiwara; Koji Tsuta; Hiroshi Nokihara; Tomohide Tamura; Hisao Asamura; Makoto Kawaishi; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Mol Ther       Date:  2015-01-19       Impact factor: 11.454

9.  Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis.

Authors:  Jie Ma; Ning Li; Maria Guarnera; Feng Jiang
Journal:  Biomark Insights       Date:  2013-11-14

10.  Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung Cancer.

Authors:  Jie Ma; Ning Li; Yanli Lin; Chhavi Gupta; Feng Jiang
Journal:  Biomark Cancer       Date:  2016-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.